Increasing infectious diseases and global travel trends are fueling the Oral Vaccine Market 2026

Global Oral Vaccine Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Oral Vaccine Market During 2026–2030?

The oral vaccine market has experienced significant expansion recently. It is projected to increase from $3.95 billion in 2025 to $4.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.0%. This historical growth can be linked to the widespread presence of vaccine-preventable diseases, growing understanding of the benefits of immunization, government-led vaccination efforts, the introduction of oral polio and cholera vaccines, and the expansion of vaccination programs in hospitals and clinics.

The oral vaccine market is anticipated to show significant expansion in the coming years. It is projected to achieve a value of $6.29 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.7%. This expected growth during the forecast period is driven by the introduction of new oral vaccines (including DNA, RNA, and VLP variants), the expansion of global immunization initiatives, the integration of digital health and monitoring solutions, increasing investment in vaccine research and development, and a greater emphasis on adult and travel vaccinations. Prominent trends throughout the projection period involve the increasing use of oral vaccines for pediatric immunization, an intensified focus on preventive healthcare and widespread vaccination programs, the creation of live attenuated and subunit oral vaccines, the scaling up of government-supported immunization campaigns, and the incorporation of cold chain and logistics innovations for vaccine distribution.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27373&type=smp

What Underlying Factors Are Accelerating The Growth Of The Oral Vaccine Market?

An increase in the occurrence of infectious diseases is anticipated to boost the expansion of the oral vaccine market in the future. These conditions stem from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can spread among people or via the surroundings. The rise in infectious diseases is attributed to growing global travel, facilitating the swift transit of individuals and pathogens across national boundaries, thereby hastening the global dissemination of infections. Oral vaccines prove advantageous for combating infectious diseases by stimulating mucosal immunity within the gut, a key entry point for numerous pathogens, thus providing robust protection directly at the infection site. For instance, in May 2025, according to the Health Security Agency, a UK-based government department, in England, the number of reported tuberculosis (TB) cases in 2023 showed an 11.0% increase compared to 2022. Consequently, the growing prevalence of infectious diseases is fueling the development of the oral vaccine market.

How Are The Various Segments Of The Oral Vaccine Market Categorized?

The oral vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Other Vaccine Types

2) By Application: Polio, Cholera, Other Applications

3) By End-User: Hospital , Clinics, Government Organization, Other End-Users

Subsegments:

1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV), Rotavirus Vaccine, Oral Typhoid Vaccine, Oral Cholera Vaccine

2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV), Inactivated Cholera Vaccine, Inactivated Hepatitis A Vaccine

3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Vaccines, Conjugate Vaccines

4) By Other Vaccine Types: Virus-Like Particle (VLP) Vaccines, Recombinant Vector Vaccines

What Trends Are Affecting The Expansion Of The Oral Vaccine Market?

Major companies in the oral vaccine market are prioritizing the development of innovative products, such as second-generation oral pill vaccines, to improve immune response and ease of administration. A second-generation pill-based oral vaccine aims to enhance immunogenicity, broaden protection, and streamline mass immunization, eliminating the need for needles or cold-chain storage. For instance, in March 2025, Vaxart Inc., a U.S.-based biotechnology company, announced the launch of a Phase 1 clinical trial for its second-generation oral norovirus vaccine, provided in a pill formulation. This trial will evaluate improved immune responses and safety features of the updated constructs, seeking to address the ongoing global requirement for accessible and effective norovirus immunization. The pill format removes typical barriers associated with injectable vaccines and supports rapid, large-scale distribution, particularly during outbreaks.

Which Major Firms Influence Developments In The Oral Vaccine Market?

Major companies operating in the oral vaccine market are Panacea Biotec Ltd., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Haffkine Biopharmaceutical Co. Ltd., Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.

Read the full oral vaccine market report here:

https://www.thebusinessresearchcompany.com/report/oral-vaccine-global-market-report

Which Region Is Projected To Dominate The Oral Vaccine Market During The Forecast Period?

North America was the largest region in the oral vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oral Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27373&type=smp

Browse Through More Reports Similar to the Global Oral Vaccine Market 2026, By The Business Research Company

Sandwich Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Polyurethane Sealants Pu Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyurethane-sealants-pu-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model